Summit Hotel Properties (INN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
Sequential RevPAR improvement in Q4 2025, with demand stabilizing despite macroeconomic and policy headwinds; full-year 2025 saw a net loss of $23.6 million and a 1.8% same-store RevPAR decline, mainly due to lower ADR and reduced government/international demand.
Disciplined capital recycling continued, with three non-core hotels sold since Q4 2025 for over $51 million, reducing near-term capex needs by $13 million.
No debt maturities until 2028 after refinancing $288M convertible notes with a $275M delayed draw term loan.
Positioned for long-term value creation through market share gains, expense management, and portfolio investment.
Total revenues for 2025 were $729.5 million, slightly down year-over-year.
Financial highlights
Q4 2025 pro forma RevPAR declined 1.8% year-over-year to $115.58; full-year RevPAR was $121.85, down 2.2%.
Adjusted EBITDA for Q4 was $39.7 million; full-year adjusted EBITDA was $174.8 million, both reflecting declines from 2024.
Adjusted FFO for Q4 was $22.3 million ($0.18/share); full-year adjusted FFO was $103.6 million ($0.85/share).
Hotel EBITDA margin for Q4 was 31.7%, down 239 bps; full-year margin was 33.4%, down 223 bps.
Pro forma operating expenses rose ~2% year-over-year; contract labor costs declined nearly 9%.
Outlook and guidance
2026 RevPAR expected to be flat to up 3%, driven by ADR gains and easing government/international comps.
Adjusted EBITDA guidance for 2026: $167M–$181M; adjusted FFO: $89M–$103.5M ($0.73–$0.85/share).
Margins expected flat to down 100 bps; operating expenses to rise 2%-3% year-over-year.
Capital expenditures for 2026 projected at $55M–$65M.
World Cup exposure expected to add 50–75 bps to full-year RevPAR growth.
Latest events from Summit Hotel Properties
- Hotel REIT registers $500M in securities and 12.9M shares, targeting growth in top U.S. markets.INN
Registration Filing25 Feb 2026 - Q2 2024 saw record net income, margin gains, and deleveraging from asset sales.INN
Q2 20242 Feb 2026 - Adjusted FFO and EBITDAre rose as asset sales improved portfolio quality despite hurricane impacts.INN
Q3 202416 Jan 2026 - Q1 RevPAR up 1.5%, $4.7M net loss, $275M refinancing, $50M buyback approved.INN
Q1 202527 Dec 2025 - Net income and AFFO per share rose in 2024; 2025 outlook calls for continued growth.INN
Q4 202423 Dec 2025 - Annual meeting covers director elections, auditor ratification, say-on-pay, and ESG progress.INN
Proxy Filing2 Dec 2025 - Key votes include director elections, auditor ratification, and executive pay approval.INN
Proxy Filing2 Dec 2025 - Q2 2025 delivered lower earnings but improved liquidity, extended debt maturities, and share buybacks.INN
Q2 202523 Nov 2025 - Q3 2025 saw flat revenues, lower RevPAR, and share repurchases amid industry headwinds.INN
Q3 202513 Nov 2025